147 related articles for article (PubMed ID: 8276022)
1. Calcium metabolism in the Jansen type of metaphyseal dysplasia.
Kruse K; Schütz C
Eur J Pediatr; 1993 Nov; 152(11):912-5. PubMed ID: 8276022
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
Kruse K
J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies on phosphate handling in hypercalcaemia.
Wikström B; Ljunghall S; Wide L; Akerström G
Acta Med Scand; 1982; 212(6):413-20. PubMed ID: 6297262
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
5. Familial benign hypercalcaemia. Study of a large family.
Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
7. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
Pak CY; Oata M; Lawrence EC; Snyder W
J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling.
Gallacher SJ; Fraser WD; Patel U; Logue FC; Soukop M; Boyle IT; Ralston SH
Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():551-6. PubMed ID: 1964370
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.
Ralston SH; Cowan RA; Gardner MD; Fraser WD; Marshall E; Boyle IT
Clin Endocrinol (Oxf); 1987 Mar; 26(3):281-91. PubMed ID: 3652475
[TBL] [Abstract][Full Text] [Related]
10. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
11. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
[TBL] [Abstract][Full Text] [Related]
12. Hereditary hypophosphatemic rickets with hypercalciuria.
Tieder M; Modai D; Samuel R; Arie R; Halabe A; Bab I; Gabizon D; Liberman UA
N Engl J Med; 1985 Mar; 312(10):611-7. PubMed ID: 2983203
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
14. Familial hypocalciuric hypercalcaemia: observations on vitamin D metabolism and parathyroid function.
Davies M; Adams PH; Berry JL; Lumb GA; Klimiuk PS; Mawer EB; Wain D
Acta Endocrinol (Copenh); 1983 Oct; 104(2):210-5. PubMed ID: 6314724
[TBL] [Abstract][Full Text] [Related]
15. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
16. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
Bastepe M; Raas-Rothschild A; Silver J; Weissman I; Wientroub S; Jüppner H; Gillis D
J Clin Endocrinol Metab; 2004 Jul; 89(7):3595-600. PubMed ID: 15240651
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism.
Parfitt AM; Schipani E; Rao DS; Kupin W; Han ZH; Jüppner H
J Clin Endocrinol Metab; 1996 Oct; 81(10):3584-8. PubMed ID: 8855805
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D status in primary hyperparathyroidism in India.
Harinarayan CV; Gupta N; Kochupillai N
Clin Endocrinol (Oxf); 1995 Sep; 43(3):351-8. PubMed ID: 7586606
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
